About Takeda Oncology

Takeda-Oncology-Leadership-Headshot-Liz-Lewis.jpg

Liz Lewis

Head, Global Oncology Patient Value, Policy and Access, Oncology Business Unit

Liz Lewis is Head of Global Oncology Patient Value, Policy and Access, OBU at Takeda and is responsible for accelerating Takeda’s efforts in securing rapid and broad patient access and continuing to strengthen Takeda’s patient advocacy and policy approach and initiatives.

Since joining Takeda in 2002, Ms. Lewis has led the Legal function supporting the Specialty BUs/R&D (including oncology) and was a key leader in rolling out the global Legal function. She has transformed the Patient Advocacy function to reflect Takeda’s strategic imperatives and emphasis on embedding the patient perspective into all phases of development and commercialization. An active participant in industry trade organizations, Ms. Lewis is on the Board of Directors for Massachusetts Biotechnology Council (MassBio), is on the Board of Directors for the Network for Excellence in Health Innovation (NEHI) and a member of the Health Section Governing Board for Biotechnology Innovation Organization (BIO) where she co-chairs the Access and Value Committee.

Before joining Takeda, Ms. Lewis was a partner at the Washington, DC-based law firm Epstein, Becker and Green, where she represented healthcare and life science companies, co-chairing the firm’s pharmaceutical practice group.

Ms. Lewis holds a BA in Government with honors from Hamilton College and received her JD at American University Washington College of Law.